EUVIMEDEUVIMED entdecken
Open Access

Retraction: LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR5095p to modulate FOXP1 expression

Yueli Gu, Xichun Xiao, Shuo Yang

Oncotarget · 06.01.2026 · 17 (1) · 250-250

DOI: 10.18632/oncotarget.28885 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, erschienen am 06.01.2026. Verfasst von Yueli Gu und 2 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Gu, Y., Xiao, X., & Yang, S. (2026). Retraction: LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR5095p to modulate FOXP1 expression. Oncotarget, 17(1), 250-250. https://doi.org/10.18632/oncotarget.28885

Vancouver

Gu Y, Xiao X, Yang S. Retraction: LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR5095p to modulate FOXP1 expression. Oncotarget. 2026;17(1):250-250. doi:10.18632/oncotarget.28885

BibTeX
@article{Gu2026,
  author = {Gu, Yueli and Xiao, Xichun and Yang, Shuo},
  title = {Retraction: LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR5095p to modulate FOXP1 expression},
  journal = {Oncotarget},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {250--250},
  doi = {10.18632/oncotarget.28885}
}
Kostenlos starten →